PulmCCM

Share this post
Biggest losers shed 22 pounds in Qnexa weight loss drug trial
www.pulmccm.org

Biggest losers shed 22 pounds in Qnexa weight loss drug trial

Apr 25, 2011
Share this post
Biggest losers shed 22 pounds in Qnexa weight loss drug trial
www.pulmccm.org

Fen-phen died in court, but phenteramine was cleared of all serious charges. Gadde et al report phase III results for Qnexa (by Vivus), a phenteramine-topiramate combination. Over 56 weeks, takers of a double-dose of study drug lost 10 kg; single-dose, 8 kg; and placebo, 1.4 kg. There were plenty of side effects (dry mouth and paresthesias 20%; dysgeusia, insomnia, dizziness, depression & anxiety-related adverse events each in 7% or more at the high dose).(n=2,487). Lancet 2011;377:1341-1352.

Share this post
Biggest losers shed 22 pounds in Qnexa weight loss drug trial
www.pulmccm.org
Comments
TopNew

No posts

Ready for more?

© 2023 PulmCCM
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing